Mepolizumab for severe eosinophilic asthma - real-life data

被引：0
|
作者：
Braganca, M. [1 ]
Amaral, L. [1 ]
Placido, J. L. [1 ]
机构：
[1] CHU Sao Joao, Serv Imunoalergol, Porto, Portugal
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
92
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [1] Real-life treatment of severe eosinophilic asthma with mepolizumab
    Pelaia, Corrado
    Busceti, Maria Teresa
    Solinas, Sabina
    Terracciano, Rosa
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Mepolizumab in real-life treatment of severe eosinophilic asthma
    Volakova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] A real-life cohort of mepolizumab treatment in severe eosinophilic asthma
    Laorden, Daniel
    Hernandez, Irene
    Dominguez-Ortega, Javier
    Romero, David
    Alvarez-Sala, Rodolfo
    Quirce, Santiago
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 56 (04) : 169 - 175
  • [4] Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Idzko, Marco
    Pohl, Wolfgang
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 64
  • [5] Mepolizumab for the treatment of severe eosinophilic asthma: A real-life study of 27 patients
    Masciopinto, L.
    Lovecchio, A.
    Cascavilla, M. T.
    Laudadio, V
    Frisenda, F. M.
    Pasculli, C.
    Di Girolamo, A.
    Sinisi, A.
    Minenna, E.
    Albanesi, M.
    Di Bona, D.
    Caiaffa, M. F.
    Macchia, L.
    ALLERGY, 2019, 74 : 446 - 446
  • [6] A real-life comparison of patients with severe eosinophilic asthma treated with benralizumab or mepolizumab
    Andersen, Helle H.
    Smidt-Hansen, Torben
    Pedersen, Lene M.
    Skjold, Tina
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study
    Nazik Bahcecioglu, Sakine
    TURK, Murat
    ATAYIK, Emel
    PACACI CETIN, Gulden
    ARSLAN, Bahar
    GULMEZ, Inci
    YILMAZ, Insu
    ASTIM ALLERJI IMMUNOLOJI, 2022, 20 (02): : 81 - 86
  • [8] Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities
    Crimi, Claudia
    Campisi, Raffaele
    Cacopardo, Giulia
    Intravaia, Rossella
    Nolasco, Santi
    Porto, Morena
    Pelaia, Corrado
    Crimi, Nunzio
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (09):
  • [9] Results in clinical practice in the treatment of severe eosinophilic asthma with mepolizumab: a real-life study
    Isabel Enriquez-Rodriguez, Ana
    Hermida Valverde, Tamara
    Romero Alvarez, Pedro
    Julian Lopez-Gonzalez, Francisco
    Gullon Blanco, Jose Antonio
    Exposito Villegas, Ana Rosa
    Escobar Fernandez, Maria Jose
    Beristain Urquiza, Ana Maria
    Alonso Fernandez, Miguel Angel
    Rodriguez, Margarita Gutierrez
    De las Pozas, Gema Castano
    Perez, Jennifer Jimenez
    Mellado, Roberto Fernandez
    Garcia Clemente, Marta Maria
    Clara, Pere Casan
    JOURNAL OF ASTHMA, 2022, 59 (05) : 1005 - 1011
  • [10] Real-life experience with mepolizumab in the French early access program for severe eosinophilic asthma
    Gruber, Alina
    Taille, Camille
    Chanez, Pascal
    Devouassoux, Gilles
    Didier, Alain
    Pison, Christophe
    Garcia, Gilles
    Bourdin, Arnaud
    Pribil, Celine
    Humbert, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345